ProPhase Labs logo

ProPhase LabsNASDAQ: PRPH

Profile

Sector:

Healthcare

Country:

United States

IPO:

04 April 1994

Next earnings report:

08 November 2024

Last dividends:

24 May 2022

Next dividends:

N/A
$40.83 M
-82%vs. 3y high
32%vs. sector
-vs. 3y high
-vs. sector
-72%vs. 3y high
39%vs. sector
-51%vs. 3y high
40%vs. sector

Price

regular market | Fri, 01 Nov 2024 13:30:00 GMT
$2.14-$0.15(-6.55%)
$2.47 M$23.85 M
$2.47 M-$6.15 M

Analysts recommendations

Institutional Ownership

PRPH Latest News

ProPhase Labs Announces Positive Updates on Strategic Initiatives Company Anticipates Multiple Liquidity Events in H1 2025
globenewswire.com17 October 2024 Sentiment: POSITIVE

Projections for Pharmaloz Manufacturing: Approximately $16-17 Million in Revenue, $6-7 Million in Pre-Tax Earnings for 2025

ProPhase Labs to Present at August 20th Virtual Investor Summit Microcap Event
globenewswire.com19 August 2024 Sentiment: POSITIVE

GARDEN CITY, NY, Aug. 19, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics, and diagnostics company, today announced that it will be presenting at the Virtual Investor Summit Microcap Event. The company will be available for 1-on-1 meetings throughout the day in addition to their presentation.

ProPhase Labs, Inc. (PRPH) Q2 2024 Earnings Call Transcript
seekingalpha.com14 August 2024 Sentiment: NEUTRAL

ProPhase Labs, Inc. (NASDAQ:PRPH ) Q2 2024 Earnings Conference Call August 14, 2024 11:00 AM ET Company Participants Noella Alexander-Young - Renmark Financial Communications Ted Karkus - Chief Executive Officer Conference Call Participants Hunter Diamond - Diamond Equity Noella Alexander-Young Hello and good morning, everyone. Welcome to today's presentation.

PROPHASE LABS INC. TO PRESENT SECOND QUARTER 2024 FINANCIAL RESULTS ON AUGUST 14
globenewswire.com07 August 2024 Sentiment: POSITIVE

GARDEN CITY, NY, Aug. 07, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), announced today that they will be presenting second quarter 2024 financial results on a virtual conference call hosted by Renmark Financial on August 14, 2024 at 11:00 am EDT. A press release detailing these results will be issued prior to the virtual conference call. ProPhase Labs Inc. welcomes stakeholders, investors, and other individual followers to register and attend this live event.

ProPhase Labs Announces Update on Pharmaloz Manufacturing, Inc. Progress
globenewswire.com11 July 2024 Sentiment: POSITIVE

PMI Revenues and Earnings Projected to Grow Significantly in the Second Half of 2024 and Full Year 2025. New Strategic Initiatives for PMI Create Significant Opportunities for Liquidity and Value Creation Garden City, NY, July 11, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics, and diagnostics company, today reported that Pharmaloz Manufacturing, Inc. (“PMI”), its wholly-owned subsidiary, is projecting significant revenues and earnings growth for the second half of 2024 and the entire year of 2025.

ProPhase Labs, Inc. (PRPH) Q4 2023 Earnings Call Transcript
Seeking Alpha15 March 2024 Sentiment: POSITIVE

ProPhase Labs, Inc. (PRPH) Q4 2023 Earnings Call Transcript

ProPhase Labs, Inc. (PRPH) Q3 2023 Earnings Call Transcript
Seeking Alpha09 November 2023 Sentiment: POSITIVE

ProPhase Labs, Inc. (NASDAQ:PRPH ) Q3 2023 Earnings Conference Call November 9, 2023 11:00 AM ET Company Participants Ted Karkus - Chairman and CEO Conference Call Participants Adam Waldo - Lismore Partners Yi Chen - H.C. Wainwright Hunter Diamond - Diamond Equity Dennis Waldman - Barrett Productions Operator Good day and welcome the ProPhase Labs Incorporated Third Quarter 2023 Financial Results and Corporate Update.

ProPhase Labs, Inc. (PRPH) Q2 2023 Earnings Call Transcript
Seeking Alpha12 August 2023 Sentiment: POSITIVE

ProPhase Labs, Inc. (NASDAQ:PRPH ) Q2 2023 Earnings Conference Call August 10, 2023 11:00 AM ET Company Participants Ted Karkus - Chairman and CEO Conference Call Participants Adam Waldo - Lismore Partners Dennis Waldman - Barrett Productions Yi Chen - H.C. Wainwright Operator Good day, and welcome to the ProPhase Labs Second Quarter 2023 Financial Results and Corporate Update.

ProPhase Labs Announces Updated Conference Call Dial-in Information for Thursday August 10, 2023 at 11:00 a.m. Eastern Time for Second Quarter 2023 Financial Results Call.
GlobeNewsWire10 August 2023 Sentiment: NEGATIVE

Garden City, NY, Aug. 10, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) Conference Call and Webcast Details Management will host a conference call at 11:00 AM ET, Thursday, August 10, 2023, to provide an update on corporate developments and review financial results. Following management's formal remarks, there will be a question-and-answer session.

ProPhase Labs to Host Second Quarter 2023 Financial Results Conference Call on Thursday, August 10, 2023 at 11:00 a.m. Eastern Time
GlobeNewsWire02 August 2023 Sentiment: POSITIVE

GARDEN CITY, NY, Aug. 02, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a next generation biotech, genomics, therapeutics and diagnostics company, will hold a conference call on Thursday, August 10, 2023, at 11:00 a.m. Eastern time to discuss its results for the second quarter ended June 30, 2023 and provide a business update. A press release detailing these results will be issued prior to the call.

What type of business is ProPhase Labs?

ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of TK supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. It offers contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; COVID-19 diagnostic information services to a range of customers, including health plans, third party payers, and government organizations; and respiratory pathogen panel molecular testing services, as well as personal genomics products and services. In addition, the company involved in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements; and retail operations. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.

What sector is ProPhase Labs in?

ProPhase Labs is in the Healthcare sector

What industry is ProPhase Labs in?

ProPhase Labs is in the Diagnostics & Research industry

What country is ProPhase Labs from?

ProPhase Labs is headquartered in United States

When did ProPhase Labs go public?

ProPhase Labs initial public offering (IPO) was on 04 April 1994

What is ProPhase Labs website?

https://www.prophaselabs.com

Is ProPhase Labs in the S&P 500?

No, ProPhase Labs is not included in the S&P 500 index

Is ProPhase Labs in the NASDAQ 100?

No, ProPhase Labs is not included in the NASDAQ 100 index

Is ProPhase Labs in the Dow Jones?

No, ProPhase Labs is not included in the Dow Jones index

When was ProPhase Labs the previous earnings report?

No data

When does ProPhase Labs earnings report?

The next expected earnings date for ProPhase Labs is 08 November 2024